UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 365

Sortiert nach

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

Circulation (New York, N.Y.), 1982-05, Vol.65 (5), p.879-885

1982

Volltextzugriff (PDF)

Pharmacokinetics of flecainide in patients with cirrhosis of the liver

Clinical pharmacology and therapeutics, 1988-11, Vol.44 (5), p.566-572

1988

Volltextzugriff (PDF)

Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

Clinical pharmacology and therapeutics, 1989-07, Vol.46 (1), p.1-8

1989

Volltextzugriff (PDF)

Metabolism of flecainide

The American journal of cardiology, 1984-02, Vol.53 (5), p.B41-B51

1984

Volltextzugriff (PDF)

Oral Flecainide Pharmacokinetics in Patients with Impaired Renal Function

Journal of clinical pharmacology, 1988-03, Vol.28 (3), p.259-267

1988

Volltextzugriff (PDF)

Quantitation of Flecainide Acetate, A New Antiarrhythmic Agent, in Biological Fluids by Gas Chromatography with Electron-Capture Detection

Journal of pharmaceutical sciences, 1984-10, Vol.73 (10), p.1469-1471

1984

Volltextzugriff (PDF)

The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance

European journal of clinical pharmacology, 1987, Vol.33 (1), p.97-99

1987

Volltextzugriff (PDF)

The development and testing of intravenous dosing regimens: Application to flecainide for the suppression of ventricular arrhythmias

Clinical pharmacology and therapeutics, 1988-05, Vol.43 (5), p.499-508

1988

Volltextzugriff (PDF)

The Effect of Flecainide Acetate, a New Antiarrhythmic, on Plasma Digoxin Levels

Journal of clinical pharmacology, 1986-01, Vol.26 (1), p.27-31

1986

Volltextzugriff (PDF)

Oral flecainide acetate for the treatment of ventricular arrhythmias

The New England journal of medicine, 1981-08, Vol.305 (9), p.473

1981

Volltextzugriff (PDF)

Biotransformation and elimination of 14C-flecainide acetate in humans

Drug metabolism and disposition, 1984-07, Vol.12 (4), p.414

1984

Volltextzugriff (PDF)

Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans

Clinical therapeutics, 1984, Vol.6 (5), p.643

1984

Volltextzugriff (PDF)

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide

The American journal of cardiology, 1981-12, Vol.48 (6), p.1133-1140

1981

Volltextzugriff (PDF)

Relationship of Drug Metabolism and Inflammation to the Gingival Response of Rats Treated with Diphenylhydantoin

Journal of dental research, 1975-06, Vol.54 (2_suppl), p.68-74

1975

Volltextzugriff (PDF)

The relationship of 5,5-diphenylhydantoin metabolism to the species-specific induction of gingival hyperplasia in the rat

Archives of oral biology, 1972-02, Vol.17 (2), p.311-321

1972

Volltextzugriff (PDF)

Flecainide Pharmacokinetics After Multiple Dosing in Patients with Impaired Renal Function

Journal of clinical pharmacology, 1988-08, Vol.28 (8), p.727-735

1988

Volltextzugriff (PDF)

Levels of 5,5-Diphenylhydantoin and its Major Metabolite in Human Serum, Saliva, and Hyperplastic Gingiva

Journal of dental research, 1974-11, Vol.53 (6), p.1323-1329

1974

Volltextzugriff (PDF)

Monomer release from methacrylate bone cements during simulated in vivo polymerization

Journal of biomedical materials research, 1979-01, Vol.13 (1), p.135-147

1979

Volltextzugriff (PDF)

Liquid Scintillation Measurement of Radioactivity in Hard Tissue Abrasion Slurries

Journal of dental research, 1972-09, Vol.51 (5), p.1501-1501

1972

Volltextzugriff (PDF)

Binding of 5,5-Diphenylhydantoin and Its Major Metabolite to Human and Rat Plasma Proteins

Journal of pharmaceutical sciences, 1971-11, Vol.60 (11), p.1642-1646

1971

Volltextzugriff (PDF)

Measurement of flecainide acetate in human plasma by an extraction spectrophotofluorometric method

Arzneimittel-Forschung, 1983, Vol.33 (2), p.251

1983

Volltextzugriff (PDF)

Synthesis of N-(2-piperidylmethyl)-2,5-BIS(2,2,2-trifluoroethoxy)benzamide-carbonyl-14C acetate (flecainide-14C acetate)

Journal of labelled compounds & radiopharmaceuticals, 1981-05, Vol.18 (5), p.713-720

1981

Volltextzugriff (PDF)

Synthesis of N‐(2‐piperidylmethyl)‐2,5‐BIS(2,2,2‐trifluoroethoxy)benzamide‐carbonyl‐ 14 C acetate (flecainide‐ 14 C acetate)

Journal of labelled compounds & radiopharmaceuticals, 1981-05, Vol.18 (5), p.713-720

1981

Volltextzugriff (PDF)

Felcainide pharmacokinetics after multiple dosing in patients with impaired renal function

Journal of clinical pharmacology, 1988, Vol.28 (8), p.727-735

1988

Volltextzugriff (PDF)

Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients

Arzneimittel-Forschung, 1982, Vol.32 (2), p.155

1982

Volltextzugriff (PDF)

1 – 25 von 365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(285)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(217)
Humans
(140)
Life Sciences & Biomedicine
(125)
Physical Sciences
(78)
Female
(74)
Male
(53)
Cardiovascular System & Cardiology
(52)
Biological And Medical Sciences
(49)
Hematology
(48)
Middle Aged
(48)
Peripheral Vascular Disease
(48)
Adult
(47)
Medical Sciences
(45)
Physics
(33)
Technology
(29)
Aged
(27)
Astronomy & Astrophysics
(27)
Science & Technology - Other Topics
(26)
Risk Factors
(22)
Animals
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

Pharmacokinetics of flecainide in patients with cirrhosis of the liver

Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate

Metabolism of flecainide

Oral Flecainide Pharmacokinetics in Patients with Impaired Renal Function

Quantitation of Flecainide Acetate, A New Antiarrhythmic Agent, in Biological Fluids by Gas Chromatography with Electron-Capture Detection

The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance

The development and testing of intravenous dosing regimens: Application to flecainide for the suppression of ventricular arrhythmias

The Effect of Flecainide Acetate, a New Antiarrhythmic, on Plasma Digoxin Levels

Oral flecainide acetate for the treatment of ventricular arrhythmias

Biotransformation and elimination of 14C-flecainide acetate in humans

Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide

Relationship of Drug Metabolism and Inflammation to the Gingival Response of Rats Treated with Diphenylhydantoin

The relationship of 5,5-diphenylhydantoin metabolism to the species-specific induction of gingival hyperplasia in the rat

Flecainide Pharmacokinetics After Multiple Dosing in Patients with Impaired Renal Function

Levels of 5,5-Diphenylhydantoin and its Major Metabolite in Human Serum, Saliva, and Hyperplastic Gingiva

Monomer release from methacrylate bone cements during simulated in vivo polymerization

Liquid Scintillation Measurement of Radioactivity in Hard Tissue Abrasion Slurries

Binding of 5,5-Diphenylhydantoin and Its Major Metabolite to Human and Rat Plasma Proteins

Measurement of flecainide acetate in human plasma by an extraction spectrophotofluorometric method

Synthesis of N-(2-piperidylmethyl)-2,5-BIS(2,2,2-trifluoroethoxy)benzamide-carbonyl-14C acetate (flecainide-14C acetate)

Synthesis of N‐(2‐piperidylmethyl)‐2,5‐BIS(2,2,2‐trifluoroethoxy)benzamide‐carbonyl‐ 14 C acetate (flecainide‐ 14 C acetate)

Felcainide pharmacokinetics after multiple dosing in patients with impaired renal function

Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients

Suchergebnisse filtern